Quoin Pharmaceuticals, Ltd.
(NASDAQ: QNRX)
|
5:30 PM UTC, 07/03/24 | |||
---|---|---|---|---|
Last: $0.58 | Change: +0.00 | %Change: +0.38% | Volume: 12,206 |
Open: | $ 0.61 | Volume: | 12,206 | |
---|---|---|---|---|
High: | $ 0.61 | Yield(%) | 0.00 | |
Low: | $ 0.57 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 2.20M | |
EPS ($) | -7.54 | Shares Out: | 3.80M |
% Price Change (last 4 weeks): | -19.87 |
---|---|
% Price Change (last 13 weeks): | -34.74 |
% Price Change (last 26 weeks): | -88.06 |
% Price Change (last 52 weeks): | -90.22 |
% Price Change (year to date): | -88.18 |
Return on Equity (%): | -132.57 |
---|---|
Return on Assets (%): | -65.08 |
Return on Invested Capital (%): | -276.29 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | n/a |
Operating Profit Margin (%): | 0.00 |
|
|
50-day Moving Average: | $0.70 |
---|---|
200-day Moving Average: | $2.74 |
Avg. Daily Vol. (last 50 days): | 54,633 |
Avg. Daily Vol. (last 200 days): | 218,492 |
52-wk high: | $12.00 |
52-wk low: | $0.57 |
Bid: | $0.58 |
Ask: | $0.60 |
Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.
|
Quoin Pharmaceuticals, Ltd.
42127 Pleasant Forest Court Ashburn VA 20148-7349 Phone: 1.703.980.4182 Fax: n/a http://www.quoinpharma.com |
Earnings (1year) ($): | -7.54 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 5.74 |
Cash Flow ($): | -8.67 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | n/a |
Price/Book (x): | 0.85 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 3.15 |
---|---|
Current Ratio (x): | 3.15 |
LT Debt/Equity (x): | 0.00 |
Total Debt/Equity (x): | 0.00 |